Stellate Ganglion Block for Preserving Arteriovenous Fistula in Hemodialysis Patients Undergoing Major Lower Limb Orthopedic Surgery: A Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of this study is to evaluate the role of stellate ganglion blockade (SGB) for preserving arteriovenous fistula in hemodialysis patients undergoing major lower limb orthopedic surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 75
Healthy Volunteers: f
View:
• Age 21 to 75 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status III.
• Chronic renal failure (CRF) patients.
• Undergoing major lower limb orthopedic surgery.
Locations
Other Locations
Egypt
Aswan University
RECRUITING
Aswān
Contact Information
Primary
Ayman M Eldemrdash, MD
ayman.mohamady@aswu.edu.eg
00201001296116
Time Frame
Start Date: 2024-03-09
Estimated Completion Date: 2025-02-28
Participants
Target number of participants: 50
Treatments
Experimental: Stellate ganglion blockade
Patient will receive preemptive stellate ganglion blockade (SGB) just before spinal anesthesia.
No_intervention: Control group
Patient will not receive preemptive stellate ganglion blockade (SGB).
Related Therapeutic Areas
Sponsors
Leads: Aswan University